U.S., Nov. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07937943) titled 'Pharmacokinetic (PK) Study of Phytochemicals in Whole Grains (WGs)- Barley' on Nov. 09.
Brief Summary: The purpose of this research study is to identify biomarkers (measurable signs in the body like substances in blood or urine) of whole grain (WG) barley intake following an acute exposure in pharmacokinetics (how the body absorbs, processes, and gets rid of a substance or ingredient) feeding study. In this aim, investigators will conduct a randomized crossover acute pharmacokinetic study of barley. Investigators will then use a targeted metabolomics approach to identify the exposure markers of barley intake, further develop analyti...